RT Journal Article
SR Electronic
A1 Lederman, Lynne
T1 No Benefit to Adding Oxaliplatin to Capecitabine in Locally Advanced Rectal Adenocarcinoma
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 22
SP 14
OP 15
DO 10.1177/155989771422010
UL http://mdc.sagepub.com/content/14/22/14.abstract
AB Treatment options for locally advanced rectal cancer include chemotherapy, surgery, and radiation therapy. It is not known if adding oxaliplatin to capecitabine would increase the efficacy of chemotherapy for patients with locally advanced rectal cancer. This article reports the disease-free survival (DFS) results from the interim analysis of Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer [PETACC-6; NCT00766155].